CUV 0.33% $15.16 clinuvel pharmaceuticals limited

Ann: CEO Letter to Shareholders, page-6

  1. 82 Posts.
    lightbulb Created with Sketch. 33
    As a non investor but wanting to get in, this letter does no good other than to remind that they need to invent new product as current one has done its part and they may need to raise capital. I read about this from analyst report earlier but coming from ceo it confirms. No wonder analysts are not interested in this stock even with such low PE. I hope I am wrong for long term holders and share price rockets after Quarterly.
    Last edited by Pallab12: 18/02/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.16
Change
-0.050(0.33%)
Mkt cap ! $759.5M
Open High Low Value Volume
$15.20 $15.21 $14.90 $606.6K 40.13K

Buyers (Bids)

No. Vol. Price($)
1 150 $15.15
 

Sellers (Offers)

Price($) Vol. No.
$15.20 860 1
View Market Depth
Last trade - 16.10pm 13/05/2024 (20 minute delay) ?
Last
$15.14
  Change
-0.050 ( 0.16 %)
Open High Low Volume
$15.11 $15.21 $14.95 4220
Last updated 15.59pm 13/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.